Analyst Ratings for Inovio Pharmaceuticals (INO)
INO Rating Summary
INO Price Target Summary
- Highest: $13.00 (Oppenheimer)
- Lowest: $1.80 (Jefferies)
- Average: $7.06
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$7.06 (+530.4%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Avg. $ Target:
$7.06 (+530.4%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/11/2025 | Oppenheimer » Updated 3/13/2026 |
Jay Olson | Upgrade | Outperform (Outperform) |
13.00 (N/A) |
2.12 (1.12) |
-47.17% | Details |
| 7/9/2025 | Piper Sandler » Updated 11/14/2025 |
Edward Tenthoff | New Coverage | Overweight (N/A) |
6.00 (5.00) |
1.33 (1.12) |
-15.79% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
